JP2011511823A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511823A5
JP2011511823A5 JP2010546291A JP2010546291A JP2011511823A5 JP 2011511823 A5 JP2011511823 A5 JP 2011511823A5 JP 2010546291 A JP2010546291 A JP 2010546291A JP 2010546291 A JP2010546291 A JP 2010546291A JP 2011511823 A5 JP2011511823 A5 JP 2011511823A5
Authority
JP
Japan
Prior art keywords
estradiol
dosage form
unit dosage
form according
film matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010546291A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011511823A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/051303 external-priority patent/WO2009101021A2/en
Publication of JP2011511823A publication Critical patent/JP2011511823A/ja
Publication of JP2011511823A5 publication Critical patent/JP2011511823A5/ja
Withdrawn legal-status Critical Current

Links

JP2010546291A 2008-02-13 2009-02-05 エストラジオール含有薬物の送達システム Withdrawn JP2011511823A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2830208P 2008-02-13 2008-02-13
EP08002633 2008-02-13
PCT/EP2009/051303 WO2009101021A2 (en) 2008-02-13 2009-02-05 Estradiol-containing drug delivery system

Publications (2)

Publication Number Publication Date
JP2011511823A JP2011511823A (ja) 2011-04-14
JP2011511823A5 true JP2011511823A5 (https=) 2012-02-09

Family

ID=39365963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010546291A Withdrawn JP2011511823A (ja) 2008-02-13 2009-02-05 エストラジオール含有薬物の送達システム

Country Status (27)

Country Link
US (1) US20110097405A1 (https=)
EP (1) EP2249803A2 (https=)
JP (1) JP2011511823A (https=)
KR (1) KR20100125309A (https=)
CN (1) CN101945646A (https=)
AR (1) AR070375A1 (https=)
AU (1) AU2009214193A1 (https=)
BR (1) BRPI0908477A2 (https=)
CA (1) CA2714340A1 (https=)
CL (1) CL2009000326A1 (https=)
CO (1) CO6290633A2 (https=)
CR (1) CR11632A (https=)
DO (1) DOP2010000252A (https=)
EA (1) EA201001245A1 (https=)
EC (1) ECSP10010400A (https=)
IL (1) IL206640A0 (https=)
MA (1) MA32073B1 (https=)
MX (1) MX2010008940A (https=)
NZ (1) NZ586666A (https=)
PA (1) PA8816001A1 (https=)
PE (1) PE20091471A1 (https=)
TN (1) TN2010000302A1 (https=)
TW (1) TW200940095A (https=)
UA (1) UA102680C2 (https=)
UY (1) UY31660A1 (https=)
WO (1) WO2009101021A2 (https=)
ZA (1) ZA201006517B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 HMG-CoA 환원효소 억제제를 포함하는 경구용 복합 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
WO2016140981A1 (en) * 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays
CN119055659A (zh) * 2024-09-03 2024-12-03 南通大学 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
ES2105262T3 (es) * 1992-05-18 1997-10-16 Minnesota Mining & Mfg Dispositivo de suministro de farmaco a traves de las mucosas.
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CA2329005C (en) * 1998-04-17 2006-01-03 Ortho-Mcneil Pharmaceutical, Inc. Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
ATE302790T1 (de) * 2000-04-12 2005-09-15 Schering Ag 8beta-substituierte-11beta-pentyl-und 11beta- hexyl-estra-1,3,5(10)-trienderivate
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
EP1390038A2 (en) * 2001-05-16 2004-02-25 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
JP4019374B2 (ja) * 2001-07-27 2007-12-12 アステラス製薬株式会社 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法
DE60215224T2 (de) * 2002-02-21 2007-08-23 Schering Aktiengesellschaft Pharmazeutische zusammensetzung, enthaltend ein oder mehrere steroide, eine oder mehrere tetrahydrofolatverbindungen und vitamin b12
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
CN1913876B (zh) * 2003-12-09 2013-06-26 大日本住友制药株式会社 含药物的颗粒和包含这种颗粒的固体制剂
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
DE102006003512A1 (de) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen
EP1867321A3 (en) * 2006-06-07 2008-11-19 Familplan Consulting Ltd. A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
US20080058272A1 (en) * 2006-08-29 2008-03-06 Juergen Becker Nonamer Peptides for Cancer Treatment

Similar Documents

Publication Publication Date Title
JP2011157401A5 (https=)
JP2010180236A5 (https=)
JP2011511823A5 (https=)
Cai et al. Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer
JP2013529665A5 (https=)
WO2013139111A1 (zh) 黄蜀葵花总黄酮提取物及其制备方法
IL305908B2 (en) Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104721160B (zh) 一种醋酸泼尼松片剂及其制备方法
CN106924176A (zh) 一种他莫昔芬柔性纳米脂质体凝胶剂及其制备方法
CN103961379B (zh) 一种硫磺菌提取物及用途
CN106692090A (zh) 比拉斯汀片及其制备方法
CN101045046A (zh) 巴西苏木素类化合物在制备抗肿瘤药物中的用途
CN106074588A (zh) 长柱重楼单体皂苷组合及其药物组合物和其在制药中的应用
CN102274162A (zh) 一种含有难溶性药物和亲水凝胶材料的固体组合物及其制备方法
CN101862325B (zh) 一种含有坎地沙坦酯的药物组合物
JP2013047269A5 (https=)
CN103304518A (zh) 倍半萜类化合物及其药物组合物与其在制药中的应用
CN102429893A (zh) 一种消炎抗过敏治疗口腔溃疡药及其制备方法
CN102058516B (zh) 一种固体分散体及其制剂
CN102475739B (zh) 一种丹参水提物及其制备方法
CN101897677B (zh) 一种欧前胡素缓释片及其制备方法
CN108938580A (zh) 盐酸帕罗西汀口崩片
CN106539776A (zh) 一种奥匹卡朋药物组合物及其制备方法
CN103520515B (zh) 鼓槌石斛提取物及其医药用途
CN104382870A (zh) 一种含有波拉克林钾-帕罗西汀的复合物